Odyssey Group International to Present at LD Micro Virtual Investor Conference
IRVINE, CA, June 08, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTCQB: ODYY) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique, life-saving medical products, announced today that its CEO, Michael Redmond, and Executive VP of Drug Development, Dr. Jake VanLandingham will present at the 2021 LD Micro Invitational XI Investor Conference.
Management will provide an overview of the Company's strategy in developing and acquiring life-saving medical products, including its drug candidate PRV-002, a novel neurosteroid being developed for the treatment of concussion (mild traumatic brain injury) (mTBI).
About Odyssey Group International, Inc.
For more information, visit: http://www.odysseygi.com
Media and Investors Contacts: CG CAPITAL Rich Cockrell 877.889.1972 ODYY@cg.capital
What Happens to SD-WAN in a SASE World?
ITEXPO #TECHSUPERSHOW Exhibit Hall Open
The Office Phone Reinvented (Again): Making Money with VoIP